Biondi, Andrea
Università degli Studi di Milano-Bicocca,
Italy
2025 Rank: 90815
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1675 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90815 | 74725 |
| Total Cites | 2849 | 3547 |
| H-index | 21 | 24 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 51 | 66 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 252 | 287 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2067 | 2353 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.51 |
| Self-Citation Percentage |
19.68%
|
|
Biondi, Andrea
Università degli Studi di Milano-Bicocca,
Italy
2024 Rank: 91122
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1788 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91122 | 76916 |
| Total Cites | 3089 | 3884 |
| H-index | 21 | 24 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 35 | 47 |
| Number of Single+First+Last Authored Papers | 133 | 133 |
| Total Cites to Single+First+Last Authored Papers | 207 | 244 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2294 | 2620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.48 |
| Self-Citation Percentage |
20.47%
|
|
Biondi, Andrea
Fondazione IRCCS San Gerardo dei Tintori,
Italy
2023 Rank: 83291
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1839 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83291 | 76330 |
| Total Cites | 3601 | 4463 |
| H-index | 22 | 23 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 43 | 51 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 219 | 246 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2630 | 3018 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.48 |
| Self-Citation Percentage |
19.31%
|
|
Biondi, Andrea
Università degli Studi di Milano-Bicocca,
Italy
2022 Rank: 65259
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1596 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65259 | 64740 |
| Total Cites | 3859 | 4605 |
| H-index | 22 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 53 | 60 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 245 | 284 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2775 | 3150 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.46 |
| Self-Citation Percentage |
16.20%
|
|
Biondi, Andrea
Università degli Studi di Milano-Bicocca,
Italy
2021 Rank: 79629
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1774 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79629 | 78390 |
| Total Cites | 3877 | 4536 |
| H-index | 24 | 26 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 92 | 112 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 349 | 403 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2992 | 3364 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
14.53%
|
|
Biondi, Andrea
University of Milano - Bicocca,
Italy
2020 Rank: 114015
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2306 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114015 | 106700 |
| Total Cites | 2006 | 2437 |
| H-index | 18 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 50 | 61 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 170 | 193 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1492 | 1704 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.43 |
| Self-Citation Percentage |
17.69%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.